The DOI matches its Crossref record; 42 of the 45 references it cites were found in a registry or an index.
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
Abstract
apoE-deficient mice have been created by homologous recombination in ES cells. On a low fat, low cholesterol chow diet these animals have plasma cholesterol levels of 494 mg/dl compared with 60 mg/dl in control animals, and when challenged with a high fat Western-type diet, these animals have plasma cholesterol levels of 1821 mg/dl compared with 132 mg/dl in controls. This marked hypercholesterolemia is primarily due to elevated levels of very low and intermediate density lipoproteins. At 10 weeks of age, apoE-deficient mice have already developed atherosclerotic lesions in the aorta and coronary and pulmonary arteries. apoE-deficient mice are a promising small animal model to help understand the role of apoE in vivo and the genetic and environmental determinants of atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The increased amounts of apoA-IV in VLDL and IDL we observed were seen in other reports of apoE deficiency4,5,9 and in apoE-deficient mice.31”
From Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function (2014) · cites this paper as [31]
In the citing paper
“Increased amounts of apoA-I were observed in LDL from an apoE-deficient patient9 and in VLDL from ApoE knockout mice.31”
From Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function (2014) · cites this paper as [31]
In the citing paper
“Disorders of apoE are associated with atherosclerosis, which causes dyslipidemia and myocardial infarction, and apoE-deficient mice are used as model animals for atherosclerosis2, 3).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [3]
In the citing paper
“Disorders of apoE are associated with atherosclerosis, which causes dyslipidemia and myocardial infarction, and apoE-deficient mice are used as model animals for atherosclerosis2, 3).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [3]
In the citing paper
“In vivo and in vitro studies have shown that mutations in apoE that diminish binding of apoE-containing lipoproteins to the LDL receptor are associated with high plasma cholesterol levels and cause premature atherosclerosis in humans and experimental animals ( 1-3, 7, 8 ).”
From Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4 (2011) · cites this paper as [1]
Citations
Cites
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Weber, K., & Osborn, M. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94333-4 · Cited by 16,688
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
The Metabolic Basis of Inherited Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-389_2 · Cited by 3,990
Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
Thomas, K. R., & Capecchi, M. R. (1987) · Cell · doi:10.1016/0092-8674(87)90646-5 · Cited by 2,355
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Mansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683
HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells
Hooper, M., Hardy, K., Handyside, A. H., Hunter, S., & Monk, M. (1987) · Nature · doi:10.1038/326292a0 · Cited by 1,218
A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine
Powell, L. M., Wallis, S. C., Pease, R. J., Edwards, Y. H., Knott, T. J., & Scott, J. (1987) · Cell · doi:10.1016/0092-8674(87)90510-1 · Cited by 1,045
Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
Rubin, E. M., Krauss, R. M., Spangler, E. A., Verstuyft, J. G., & Clift, S. (1991) · Nature · doi:10.1038/353265a0 · Cited by 985
Self-citation
Cited by
Sorted by citations
Items 201–300 of 1,010
Applications and Limitations of Mouse Models for Understanding Human Atherosclerosis
von Scheidt, M., Zhao, Y., Kurt, Z., Pan, C., Zeng, L., Yang, X., Schunkert, H., & Lusis, A. J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.11.001 · Cited by 230
Plump, A. S., Masucci-Magoulas, L., Bruce, C., Bisgaier, C. L., Breslow, J. L., & Tall, A. R. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.4.1105 · Cited by 222
Self-citationMicroRNA‐33 Deficiency Reduces the Progression of Atherosclerotic Plaque in ApoE −/− Mice
Horie, T., Baba, O., Kuwabara, Y., Chujo, Y., Watanabe, S., Kinoshita, M., Horiguchi, M., Nakamura, T., Chonabayashi, K., Hishizawa, M., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.003376 · Cited by 220
SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis
Stein, S., Lohmann, C., Schäfer, N., Hofmann, J., Rohrer, L., Besler, C., Rothgiesser, K. M., Becher, B., Hottiger, M. O., Borén, J., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq107 · Cited by 188
Powell-Braxton, L., Véniant, M., Latvala, R. D., Hirano, K.-I., Won, W. B., Ross, J., Dybdal, N., Zlot, C. H., Young, S. G., & Davidson, N. O. (1998) · Nature Medicine · doi:10.1038/nm0898-934 · Cited by 192
Hasty, A. H., Shimano, H., Osuga, J.-I., Namatame, I., Takahashi, A., Yahagi, N., Perrey, S., Iizuka, Y., Tamura, Y., Amemiya-Kudo, M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010176200 · Cited by 219
Dansky, H. M., Barlow, C. B., Lominska, C. E., Sikes, J. L., Kao, C., Weinsaft, J. W., Cybulsky, M. I., & Smith, J. D. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1001.096625 · Cited by 219
Self-citationRecipes for Creating Animal Models of Diabetic Cardiovascular Disease
Hsueh, W. A., Abel, E. D., Breslow, J. L., Maeda, N., Davis, R. C., Fisher, E. A. A., Dansky, H. M., McClain, D. A., McIndoe, R., Wassef, M. K., et al. (2007) · Circulation Research · doi:10.1161/01.res.0000266449.37396.1f · Cited by 221
Self-citationMouse Models of Atherosclerosis
Daugherty, A. (2002) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200201000-00002 · Cited by 218
Wu, Y., Carballo‐Jane, E., McLaren, D. G., Mendoza, V., Gagen, K., Geoghagen, N. S. M., McNamara, L. A., Gorski, J. N., Eiermann, G. J., Petrov, A., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m019927 · Cited by 229
Gallagher, E. J., Zelenko, Z., Neel, B. A., Antoniou, I. M., Rajan, L., KASE, N. G., & LeRoith, D. (2017) · Oncogene · doi:10.1038/onc.2017.247 · Cited by 222
Knight-Lozano, C. A., Young, C. G., Burow, D. L., Hu, Z., Uyeminami, D. L., Pinkerton, K. E., Ischiropoulos, H., & Ballinger, S. W. (2002) · Circulation · doi:10.1161/hc0702.103977 · Cited by 217
Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury
Chen, Y., Lomnitski, L., Michaelson, D. M., & Shohami, E. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00007-9 · Cited by 214
Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice
Gordon, I., Grauer, E., Genis, I., Sehayek, E., & Michaelson, D. M. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12006-p · Cited by 172
Mammalian acyl-CoA:cholesterol acyltransferases
Buhman, K. K. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00144-x · Cited by 214
Aortic valve disease and treatment: The need for naturally engineered solutions
Butcher, J. T., Mahler, G. J., & Hockaday, L. A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.01.008 · Cited by 220
Elhage, R., Maret, A., Pieraggi, M. T., Thiers, J., Arnal, J., & Bayard, F. (1998) · Circulation · doi:10.1161/01.cir.97.3.242 · Cited by 209
Role of Leukotriene B4Receptors in the Development of Atherosclerosis: Potential Mechanisms
Subbarao, K., Jala, V. R., Mathis, S., Suttles, J., Zacharias, W., Ahamed, J., Ali, H., Tseng, M. T., & Haribabu, B. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000110503.16605.15 · Cited by 210
Apolipoprotein E and atherosclerosis: insight from animal and human studies
Davignon, J., Cohn, J. S., Mabile, L., & Bernier, L. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00097-2 · Cited by 210
Boisvert, W. A., Spangenberg, J., & Curtiss, L. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118098 · Cited by 207
The cholesterol transporter ABCG1 links cholesterol homeostasis and tumour immunity
Sag, D., Cekic, C., Wu, R., Linden, J., & Hedrick, C. C. (2015) · Nature Communications · doi:10.1038/ncomms7354 · Cited by 205
Regulation of cholesterol homeostasis
van der Wulp, M. Y. M., Verkade, H. J., & Groen, A. K. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.007 · Cited by 210
Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability
Lillis, A. P., MIKHAILENKO, I. A., & Strickland, D. K. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01371.x · Cited by 210
Overexpression and Accumulation of Apolipoprotein E as a Cause of Hypertriglyceridemia
Huang, Y., Liu, X. Q., Rall, S. C., Taylor, J. M., von Eckardstein, A., Assmann, G., & Mahley, R. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26388 · Cited by 204
Al-Mashhadi, R. H., Sørensen, C. B., Kragh, P. M., Christoffersen, C., Mortensen, M. B., Tolbod, L. P., Thim, T., Du, Y., Li, J., Liu, Y., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004853 · Cited by 207
van Haperen, R., van Tol, A., Vermeulen, P. S., Jauhiainen, M., van Gent, T., van den Berg, P., Ehnholm, S., Grosveld, F. G., van der Kamp, A., & de Crom, R. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.4.1082 · Cited by 204
Uremia Accelerates both Atherosclerosis and Arterial Calcification in Apolipoprotein E Knockout Mice
Massy, Z. A., Ivanovski, O., Nguyen-Khoa, T., Angulo, J., Szumilak, D., Mothu, N., Phan, O., Daudon, M., Lacour, B., Dru[Combining Diaeresis]eke, T. B., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060495 · Cited by 203
Merhi‐Soussi, F., Kwak, B. R., Magne, D., Chadjichristos, C. E., Berti, M., Pelli, G., James, R. W., Mach, F., & Gabay, C. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.008 · Cited by 200
Do the Apoe −/− and Ldlr −/– Mice Yield the Same Insight on Atherogenesis?
Getz, G. S., & Reardon, C. A. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.306874 · Cited by 198
Chylomicron assembly and catabolism: role of apolipoproteins and receptors
Hussain, M. M., Kancha, R. K., Zhou, Z., Luchoomun, J., Zu, H. Y., & Bakillah, A. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00041-0 · Cited by 205
Smith, J. D., Miyata, M., Ginsberg, M. D., Grigaux, C., Shmookler, E., & Plump, A. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30647 · Cited by 197
Self-citationPurcell-huynh, D. A., Farese, R. V., Johnson, D. F., Flynn, L. M., Pierotti, V., Newland, D., Linton, M. F., Sanan, D. A., & Young, S. G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117915 · Cited by 197
Ginsberg, H. N. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70023-2 · Cited by 194
Roselaar, S. E., & Daugherty, A. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32160-x · Cited by 193
Takahashi, K. I., Takeya, M., & Sakashita, N. (2002) · Medical Molecular Morphology · doi:10.1007/s007950200023 · Cited by 192
Miettinen, H. E., Rayburn, H., & Krieger, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13288 · Cited by 192
Effects of sucrose, glucose and fructose on peripheral and central appetite signals
Lindqvist, A., Baelemans, A., & Erlanson‐Albertsson, C. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2008.06.008 · Cited by 201
Lymphocyte Populations in Atherosclerotic Lesions of ApoE −/− and LDL Receptor −/− Mice
Roselaar, S. E., Kakkanathu, P. X., & Daugherty, A. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.8.1013 · Cited by 191
Ebara, T., Ramakrishnan, R., Steiner, G. A., & Shachter, N. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119456 · Cited by 195
Terwel, D., Steffensen, K. R., Verghese, P. B., Kummer, M. P., Gustafsson, J.-Å., Holtzman, D. M., & Heneka, M. T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6546-10.2011 · Cited by 190
Apolipoprotein C1: Its Pleiotropic Effects in Lipid Metabolism and Beyond
Fuior, E. V., & Gafencu, A. V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235939 · Cited by 186
Innate and adaptive immunity in atherosclerosis
Packard, R. R. S., Lichtman, A. H., & Libby, P. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0153-8 · Cited by 191
Rapid regression of atherosclerosis: insights from the clinical and experimental literature
Williams, K. J., Feig, J. E., & Fisher, E. A. A. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1086 · Cited by 190
The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease
Beffert, U. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00008-3 · Cited by 190
Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice.
Li, H., Reddick, R. L., & Maeda, N. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.12.1814 · Cited by 189
Reducing Plasma Membrane Sphingomyelin Increases Insulin Sensitivity
Li, Z., Zhang, H., Liu, J., Liang, C.-P., Li, Y., Li, Y., Teitelman, G., Beyer, T. P., Bui, H. H., Peake, D. A., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05893-11 · Cited by 191
Kothapalli, D., Liu, S., Bae, Y., Monslow, J., Xu, T., Hawthorne, E. A., Byfield, F. J., Castagnino, P. A., Rao, S. J., Rader, D. J., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.018 · Cited by 187
Alzheimer's Disease Genetic Risk Factor APOE-ε4 Also Affects Normal Brain Function
Battista, A. M. D., Heinsinger, N. M., & Rebeck, G. W. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160401115127 · Cited by 189
Duez, H., Chao, Y., Hernandez, M., Torpier, G., Poulain, P., Mundt, S., Mallat, Z., Teissier, E., Burton, C. A., Tedgui, A., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206966200 · Cited by 201
Silence, J., Collen, D., & LIJNEN, H. R. (2002) · Circulation Research · doi:10.1161/01.res.0000016501.56641.83 · Cited by 185
Roche-Molina, M., Sanz‐Rosa, D., Cruz, F. M., García‐Prieto, J., López, S., Abia, R., Muriana, F. J. G., Fuster, V., Ibáñez, B., & Bernal, J. A. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303617 · Cited by 191
Daugherty, A., Tall, A. R., Daemen, M. J. A. P., Falk, E., Fisher, E. A. A., García‐Cardeña, G., Lusis, A. J., Owens, A. P., Rosenfeld, M. E., & Virmani, R. (2017) · Circulation Research · doi:10.1161/res.0000000000000169 · Cited by 186
Eitzman, D. T., Westrick, R. J., Xu, Z., Tyson, J. A., & Ginsburg, D. (2000) · Blood · doi:10.1182/blood.v96.13.4212 · Cited by 182
LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice
Schreyer, S. A., Vick, C. M., Lystig, T., Mystkowski, P., & LeBoeuf, R. C. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2002.282.1.e207 · Cited by 182
Patel, S. S., Thiagarajan, R., Willerson, J. T., & Yeh, E. T. H. (1998) · Circulation · doi:10.1161/01.cir.97.1.75 · Cited by 182
Phospholipid methylation in mammals: from biochemistry to physiological function
Vance, D. E. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.10.018 · Cited by 185
Willner, E. L., Tow, B., Buhman, K. K., Wilson, M. D., Sanan, D. A., Rudel, L. L., & Farese, R. V. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336398100 · Cited by 181
Wang, H., Jiang, X., Yang, F., Gaubatz, J. W., Ma, L., Magera, M. J., Yang, X.-F., Berger, P. B., Durante, W., Pownall, H. J., et al. (2003) · Blood · doi:10.1182/blood-2002-08-2606 · Cited by 180
Lemaître, V., O’Byrne, T. K., Borczuk, A., Okada, Y., Tall, A. R., & D'Armiento, J. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9626 · Cited by 180
Plump, A. S., Erickson, S. K., Weng, W., Partin, J. S., Breslow, J. L., & Williams, D. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118716 · Cited by 178
Self-citationHuang, Y., von Eckardstein, A., Wu, S., Maeda, N., & Assmann, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1834 · Cited by 180
Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis
Tan, M. H., Sun, Z., Opitz, S. L., Schmidt, T. E., Peters, J. H., & George, E. L. (2004) · Blood · doi:10.1182/blood-2003-09-3363 · Cited by 177
PAI ‐1, progress in understanding the clinical problem and its aetiology
Iwaki, T., Urano, T., & Umemura, K. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09074.x · Cited by 177
Connexins in Vascular Physiology and Pathology
Brisset, A. C., Isakson, B. E., & Kwak, B. R. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2115 · Cited by 177
Interaction of the Estrogen Receptors with the Fas Ligand Promoter in Human Monocytes
Mor, G., Sapi, E., Abrahams, V. M., Rutherford, T., Song, J. H., Hao, X.-Y., Muzaffar, S., & Kohen, F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.114 · Cited by 177
The atherogenic effect of excess methionine intake
Troen, A. M., Lutgens, E., Smith, D. E., Rosenberg, I. H., & Selhub, J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2436385100 · Cited by 180
Infectious Agents Are Not Necessary for Murine Atherogenesis
Wright, S. D., Burton, C., Hernandez, M., Hassing, H., Montenegro, J., Mundt, S., Patel, S., Card, D. J., Hermanowski-Vosatka, A., Bergstrom, J. D., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1437 · Cited by 176
Wendt, T., Bucciarelli, L. G., Qu, W., Lu, Y., Yan, S. F., Stern, D. M., & Schmidt, A. M. (2002) · Current Atherosclerosis Reports · doi:10.1007/s11883-002-0024-4 · Cited by 176
Bieghs, V., van Gorp, P. J., Wouters, K., Hendrikx, T., Gijbels, M. J., van Bilsen, M., Bakker, J. A., Binder, C. J., Lütjohann, D., Staels, B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030668 · Cited by 175
Development and Disease in Proteinase-Deficient Mice
Carmeliet, P., & Collen, D. (1998) · Thrombosis Research · doi:10.1016/s0049-3848(98)00122-4 · Cited by 174
Lichtman, A. H., Clinton, S. K., Iiyama, K., Connelly, P. W., Libby, P., & Cybulsky, M. I. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.8.1938 · Cited by 174
Chi, H.-H., Messas, E., Levine, R. A., Graves, D. T., & Amar, S. (2004) · Circulation · doi:10.1161/01.cir.0000142085.39015.31 · Cited by 176
Mayr, M., Chung, Y., Mayr, U., Yin, X., Ly, L., Troy, H., Fredericks, S., Hu, Y., Griffiths, J. R., & Xu, Q. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000183928.25844.f6 · Cited by 173
Macrophage scavenger receptors and foam cell formation
de Villiers, W. J. S., & Smart, E. J. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.5.740 · Cited by 173
Boord, J. B., Maeda, K., Makowski, L., Babaev, V. R., Fazio, S., Linton, M. F., & Hotamışlıgil, G. S. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000033090.81345.e6 · Cited by 172
Skoura, A., Michaud, J. E., Im, D., Thangada, S., Xiong, Y., Smith, J. D., & Hla, T. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.213496 · Cited by 171
Self-citationEndothelial C-type natriuretic peptide maintains vascular homeostasis
Moyes, A. J., Khambata, R. S., Villar, I. C., Bubb, K. J., Baliga, R. S., Lumsden, N. G., Xiao, F., Gane, P. J., Rebstock, A., Worthington, R. J., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74281 · Cited by 175
Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice.
Dithmar, S., Curcio, C. A., Le, N., Brown, S., & Grossniklaus, H. E. (2000) · PubMed · Cited by 171
Genetic Modifiers of Atherosclerosis in Mice
Knowles, J. W., & Maeda, N. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.11.2336 · Cited by 176
Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice
Lin, R.-Y., Choudhury, R. P., Cai, W., Lu, M. M., Fallon, J. T., Fisher, E. A. A., & Vlassara, H. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00050-9 · Cited by 169
Bonthu, S., Heistad, D. D., Chappell, D. A., Lamping, K. G., & Faraci, F. M. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2333 · Cited by 171
Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice
Caligiuri, G., Levy, B. I., Pernow, J., Thorén, P., & Hansson, G. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6920 · Cited by 171
Chronic Renal Failure Accelerates Atherogenesis in Apolipoprotein E–Deficient Mice
Bro, S., Bentzon, J. F., Falk, E., Andersen, C. B., Ølgaard, K., & Nielsen, L. B. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000088024.72216.2e · Cited by 170
Moghadasian, M. H., McManus, B. M., Godin, D. V., Rodrigues, B. B., & Frohlich, J. J. (1999) · Circulation · doi:10.1161/01.cir.99.13.1733 · Cited by 169
Sano, H., Sudo, T., Yokode, M., Murayama, T., Kataoka, H., Takakura, N., Nishikawa, S., Nishikawa, S.-I., & Kita, T. (2001) · Circulation · doi:10.1161/01.cir.103.24.2955 · Cited by 169
Atherosclerosis—An immune disease
Hansson, G. K. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.08.039 · Cited by 169
Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease
Pasterkamp, G., den Ruijter, H. M., & Libby, P. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.166 · Cited by 178
Mouse models of atherosclerosis: a historical perspective and recent advances
Lee, Y. T., Lin, H. Y., Chan, Y. W. F., Li, K. H. C., To, O. T. L., Yan, B. P., Liu, T., Li, G., Wong, W. T., Keung, W., et al. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-016-0402-5 · Cited by 183
LIPOPROTEINS AND ATHEROGENESIS
Hoeg, J. M. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70026-8 · Cited by 166
Kuipers, F., Jong, M. C., Lin, Y., Eck, M. V., Havinga, R., Bloks, V. W., Verkade, H. J., Hofker, M. H., Moshage, H. J., van Berkel, T. J. C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119841 · Cited by 167
Genetic Background Determines the Extent of Atherosclerosis in ApoE-Deficient Mice
Dansky, H. M., Charlton, S. A., Sikes, J. L., Heath, S. C., Simantov, R., Levin, L. F., Shu, P., Moore, K. J., Breslow, J. L., & Smith, J. D. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.8.1960 · Cited by 167
Self-citationApolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia
Laskowitz, D. T., Sheng, H., Bart, R. D., Joyner, K. A., Roses, A. D., & Warner, D. S. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199707000-00005 · Cited by 166
Embryonic stem cells in drug discovery
McNeish, J. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1281 · Cited by 171
Rosenblat, M., Draganov, D. I., Watson, C. E., Bisgaier, C. L., Du, B. N. L., & Aviram, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000059385.95664.4d · Cited by 166
Cohen, R. D., Castellani, L. W., Qiao, J. H., Lenten, B. J. V., Lusis, A. J., & Reue, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119358 · Cited by 165
Rouis, M., Adamy, C., Duverger, N., Lesnik, P., Horellou, P., Moreau, M., Emmanuel, F., Caillaud, J., Laplaud, P. M., Dachet, C., et al. (1999) · Circulation · doi:10.1161/01.cir.100.5.533 · Cited by 166
Impaired Clearance of Apoptotic Cells Promotes Synergy between Atherogenesis and Autoimmune Disease
Aprahamian, T. R., Rifkin, I. R., Bonegio, R. G. B., Hugel, B., Freyssinet, J., Sato, K., Castellot, J. J., & Walsh, K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031557 · Cited by 163
CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice
Kuziel, W. A., Dawson, T. C., Quinones, M. P., Garavito, É., Chenaux, G., Ahuja, S. S., Reddick, R. L., & Maeda, N. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00382-9 · Cited by 164
Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease
Manning, M. W., Cassis, L. A., Huang, J., Szilvassy, S. J., & Daugherty, A. (2002) · Vascular Medicine · doi:10.1191/1358863x02vm413ra · Cited by 163
Molecular analysis of blood vessel formation and disease
Carmeliet, P., & Collen, D. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.273.5.h2091 · Cited by 161
Metadata
- Authors
- Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L.
- Affiliations
- Rockefeller University (US)
- Lawrence Berkeley National Laboratory (US)
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1992-10
- Volume
- 71
- Issue
- 2
- Pages
- 343-353
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2048890665
- Cited by
- 2,263
- References
- 45
- Citations by year
- 2026: 23 · 2025: 41 · 2024: 28 · 2023: 32 · 2022: 52 · 2021: 39 · 2020: 60 · 2019: 69 · 2018: 57 · 2017: 66 · 2016: 57 · 2015: 71 · 2014: 71 · 2013: 82 · 2012: 75
- FWCI
- 72.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl033714-17)
- National Heart, Lung, and Blood Institute (HL 33714, R01HL032435, HL32435)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- apolipoprotein E deficiency, hypercholesterolemia, atherosclerosis, ApoE-deficient mice, homologous recombination, embryonic stem cells, serum cholesterol, VLDL, intermediate density lipoprotein, high-fat diet, aortic atherosclerotic lesions, coronary arteries, pulmonary artery, animal models of atherosclerosis
- MeSH terms
- Animals, Aorta, Apolipoproteins E, Arteriosclerosis, Cholesterol, Coronary Vessels, Disease Models, Animal, Hypercholesterolemia, Lipoproteins, Lipoproteins, VLDL, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Transgenic, Pulmonary Artery, Stem Cells, Mice, Lipoproteins, IDL
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review